As shown in Table 5, after adjusting for age and risk covariates, subjects with leptin in the highest tertile 3 had an increased risk of incident gynecological cancer as compared with those in the lowest tertile 1 (OR = 10.68, 95% CI = 2.09–54.67, p = 0.005 and OR = 11.83, 95% CI = 1.40–100.11, p = 0.023 for UCC and OVC, respectively). Here, LEP is linked to female reproductive organ cancer.